Ignite Creation Date:
2024-05-06 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05718297
Status:
WITHDRAWN
Last Update Posted:
2024-07-12
First Post:
2023-01-30
Brief Title:
Brigatinib Post Definitive Chemo-radiotherapy in Patients with ALK-fusion Non-small Cell Lung Cancer
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
ETOP IBCSG Partners Foundation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| NSCLC Stage III |
| ALK-rearrangement |
Keywords: